共查询到3条相似文献,搜索用时 16 毫秒
1.
2.
MichaelA. Müller Martin Gaplovsky Jakob Wirz Wolf‐D. Woggon 《Helvetica chimica acta》2006,89(12):2987-3001
Cytochrome P450 3A4 metabolizes a majority of administered therapeutic agents in the human liver. We recently reported the synthesis of a new inhibitor, 1 , whose binding to and displacement from the active site of CYP 3A4 can be conveniently followed by the associated changes in fluorescence intensity. Here we report the synthesis of a bichromophoric compound, 6 , in which deazaflavin was strapped over the distal side of a porphyrinatoiron(III) complex to mimic the envisaged enzyme–inhibitor interaction within the active site. Femtosecond pump–probe and fluorescence spectroscopies were used to study the photophysical processes of 6 . Rapid intramolecular energy transfer and enhanced intersystem‐crossing processes induced by the high‐spin FeIII central ion are responsible for the complete suppression of deazaflavin fluorescence in 6 . Fluorescence quenching is less efficient in the iron‐free analogue of 6 , i.e., in 21 . 相似文献